February 14, 2018 / 1:52 PM / 5 months ago

BRIEF-Myokardia Begins Patient Dosing In Phase 1B Clinical Study Of Myk-491

Feb 14 (Reuters) - Myokardia Inc:

* MYOKARDIA BEGINS PATIENT DOSING IN PHASE 1B CLINICAL STUDY OF MYK-491 IN DILATED CARDIOMYOPATHY PATIENTS

* MYOKARDIA INC - TOPLINE RESULTS FROM PHASE 1B STUDY OF MYK-491 ARE ANTICIPATED IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below